Skip to content

A Non-Randomized Controlled Study on the Effect of Intense Pulsed Light Combined with Radiofrequency on Early Scar Treatment

A Non-Randomized Controlled Study on the Effect of Intense Pulsed Light Combined with Radiofrequency on Early Scar Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114129
Enrollment
Unknown
Registered
2025-12-08
Start date
2025-12-08
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scars

Interventions

control group:none
Combined Therapy Group:Intense Pulsed light combining Radiofrequency

Sponsors

Beijing Anzhen Hospital, Affiliated of Capital University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Adults aged 18–65 years (inclusive of boundary values); 2. Time since skin injury (e.g., surgery, trauma, burn) = 5 cm², or total length of linear scars >= 5 cm; 5. No restriction on scar type (e.g., linear scars, hypertrophic scars, keloids, atrophic scars); 6. Concurrent physical therapies (e.g., massage, pressure therapy, external scar-reducing patches) are permitted (to be recorded in the Case Report Form [CRF]); 7. Voluntary participation in the study, signing of the informed consent form, and willingness to cooperate with 3-month follow-up.

Exclusion criteria

Exclusion criteria: 1. Presence of skin diseases (e.g., eczema, psoriasis) or allergic diseases in or near the treatment area, or scars still in a state of ulceration, abscess, or infection; 2. Previous receipt of other interventions for the skin injury (e.g., scar drug injection, laser therapy); 3. Allergy to the coupling gel for radiofrequency therapy or components related to intense pulsed light (IPL) therapy; 4. Pregnancy; 5. Inability to complete the prescribed treatment course and follow-up (e.g., planned long-term absence, poor compliance).

Design outcomes

Primary

MeasureTime frame
Decrease in Vancouver Scar Scale (VSS) score (total score before treatment minus total score after treatment;

Secondary

MeasureTime frame
POSAS score;scar thickness(Ultrasound detection);patient satisfaction;Incidence of adverse reactions;

Countries

China

Contacts

Public ContactHuang Lin

Beijing Anzhen Hospital, Affiliated of Capital University of Medical Sciences

shiro_yubing@hotmail.com+86 130 2128 4725

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026